Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2025-10-03 00:00:00 ET · period of report 2025-10-03 · accession 0001584759-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-10-03 | 2025-10-03 | ORIC | Heyman Richard A. | Dir | M - OptEx | $1.69 | +32.8K | 45.3K | +262% | +$55.6K |
| DM | 2025-10-03 | 2025-10-03 | ORIC | Heyman Richard A. | Dir | M - OptEx | $0.00 | -32.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-03 | M | A | 31,353 | $1.60 | 43,853 | D | — | — | |
| 2 | Common | Common Stock | 2025-10-03 | M | A | 1,447 | $3.75 | 45,300 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2025-10-03 | M | D | 1,447 | $0.00 | 52,253 | D | $3.75 · — to 2032-06-16 | 1,447 Common Stock | (F2) The shares subject to the option are fully vested and immediately exercisable. |
| 4 | Derivative | Stock Option (right to buy) | 2025-10-03 | M | D | 13,228 | $0.00 | 33,700 | D | $1.60 · — to 2028-02-28 | 13,228 Common Stock | (F2) The shares subject to the option are fully vested and immediately exercisable. |
| 5 | Derivative | Stock Option (right to buy) | 2025-10-03 | M | D | 18,125 | $0.00 | 0 | D | $1.60 · — to 2028-06-28 | 18,125 Common Stock | (F2) The shares subject to the option are fully vested and immediately exercisable. |